There are many important considerations to address in building your new drug program. Without a doubt, one of the most critical is funding to get you to your next milestone. As you grapple with funding issues, it can be useful to consider the point of view of a potential investor. 

Why? Because investors are betting on you to manage development effectively and to move quickly. In assembling this guide, we asked investment veterans and biopharma executives what questions they ask (and have been asked) when both parties sit down together. Answer these questions well and your potential investors are that much more likely to support your company’s vision.

We’ve also included a few “red flags” that you should avoid. Sometimes knowing what gives potential funders pause is just as important as knowing what they are likely to ask

By clicking 'Download Now' you agree to our Terms of Use. We take your privacy seriously. For more information please read our Privacy Policy. By registering with the Enterprise Guide you will automatically receive our weekly Product Update and Technology Insider eNewsletters.

Copyright 2021 Enterprise Guide. All Rights Reserved. Terms of Use | Privacy Policy